Hepatic fibrosis: Pathogenesis and principles of therapy

Clinics in Liver Disease

Volumn 5, Issue 2, 2001, Pages 315-334

  Albanis, Efsevia ^b   Friedman, Scott L ^b  

^a Box 1123   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIFIBROTIC AGENT; ANTIINFLAMMATORY AGENT; ARGINYLGLYCYLASPARTIC ACID; COLCHICINE; CORTICOSTEROID; ENDOTHELIN RECEPTOR ANTAGONIST; HALOFUGINONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; INTERLEUKIN 10; MALOTILATE; PENTOXIFYLLINE; QUERCETIN; RELAXIN; RESVERATROL; SILYMARIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; XIAO CHAI HU TANG;

CELL ACTIVATION; CELL PROLIFERATION; CYTOKINE RELEASE; FIBROGENESIS; HUMAN; ITO CELL; LIVER FIBROSIS; LIVER INJURY; MORBIDITY; MORTALITY; PATHOGENESIS; REVIEW; STELLATE CELL;

EID: 0035019334     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-3261(05)70168-9     Document Type: Article

References (93)

1. L. Ala-Kokko F. Stenback L. Ryhanen Preventive effect of malotilate on carbon tetrachloride-induced liver damage and collagen accumulation in the rat Biochem J 246 1987 503 509
2. L. Ala-Kokko F. Stenback L. Ryhanen Preventive effect of malotilate on dimethylnitrosamine-induced liver fibrosis in the rat J Lab Clin Med 113 1989 177 183
3. L. Beljaars B. Melgert D.K. Meijer Neoglyco- and neopeptide albumins for cell-specific delivery to chronically diseased livers H. Schreer Drug Targeting Technology: A Critical Analysis of Physical, Chemical and Biological Methods 1999 Marcel Dekker New York
4. D.M. Bissell S.S. Wang W.R. Jarnagin Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation J Clin Invest 96 1995 447 455
5. H. Bodenheimer Jr F. Schaffner J. Pezzullo Evaluation of colchicine therapy in primary biliary cirrhosis [see comments] Gastroenterology 95 1988 124 129
6. G. Boigk L. Stroedter H. Herbst Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats Hepatology 26 1997 643 649
7. S. Bronfenmajer F. Schaffner H. Popper Fat-storing cells (lipocytes) in human liver Arch Pathol 82 1966 447 453
8. K.E. Brown J.E. Poulos L. Li Effect of vitamin E supplementation on hepatic fibrogenesis in chronic dietary iron overload Am J Physiol 272 1997 G116 G123
9. R. Bruck H. Shirin R. Hershkoviz Analysis of Arg-Gly-Asp mimetics and soluble receptor of tumour necrosis factor as therapeutic modalities for concanavalin A induced hepatitis in mice Gut 40 1997 133 138
10. G. Davis R. Estevan-Mur V. Rustgi Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group N Engl J Med 339 1998 1493 1499
11. C. Dehmlow J. Erhard H. de Groot Inhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silibinin Hepatology 23 1996 749 754
12. M.C. Dufour F.S. Stinson M.F. Caces Trends in cirrhosis morbidity and mortality: United States, 1979–1988 Semin Liver Dis 13 1993 109 125
13. P. Ferenci B. Dragosics H. Dittrich Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver J Hepatology 9 1989 105 110
14. J. Fort C. Pilette N. Veal Effects of long-term administration of interferon alpha in two models of liver fibrosis in rats J Hepatol 29 1998 263 270
15. S.L. Friedman Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury J Biol Chem 275 2000 2247 2250
16. S.L. Friedman Cytokines and fibrogenesis Semin Liver Dis 19 1999 129 140
17. S.L. Friedman Hepatic stellate cells Prog Liver Dis 14 1996 101 130
18. S.L. Friedman Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies N Engl J Med 328 1993 1828 1835
19. S.L. Friedman S. Wei W.S. Blaner Retinol release by activated rat hepatic lipocytes: Regulation by Kupffer cell-conditioned medium and PDGF Am J Physiol 264 1993 G947 G952
20. M. Gallai I. Kovalszky T. Knittel Expression of extracellular matrix proteoglycans perlecan and decorin in carbon-tetrachloride-injured rat liver and in isolated liver cells Am J Pathol 148 1996 1463 1471
21. A. Geerts V. Rogiers Sho-saiko-to: The right blend of traditional Oriental medicine and liver cell biology Hepatology 29 1999 282 484
22. J. George D. Roulot V.E. Koteliansky Inhibition of rat hepatic fibrogenesis by a soluble TGF beta type II receptor Hepatology 28 1998 312A
23. M.P. Giampieri A.M. Jezequel F. Orlandi The lipocytes in normal human liver Digestion 22 1981 165 169
24. A.M. Gressner Cytokines and cellular crosstalk involved in the activation of fat-storing cells J Hepatol 22 1995 28 36
25. A.M. Gressner M.G. Bachem Cellular sources of noncollagenous matrix proteins: Role of fat-storing cells in fibrogenesis Semin Liver Dis 10 1990 30 46
26. A.M. Gressner M.G. Bachem Molecular mechanisms of liver fibrogenesis–a homage to the role of activated fat-storing cells Digestion 56 1995 335 346
27. R.J. Groszmann Nitric oxide and hemodynamic impairment Digestion 59 suppl 2 1998 6 7
28. T. Gupta M. Toruner R. Groszmann Intrahepatic modulation of portal pressure and its role in portal hypertension Role of nitric oxide. Digestion 59 4 1998 413 415
29. H.F. Hendriks W.S. Blaner H.M. Wennekers Distributions of retinoids, retinoid-binding proteins and related parameters in different types of liver cells isolated from young and old rats Eur J Biochem 171 1988 237 244
30. K. Ikeda T. Wakahara Y.Q. Wang In vitro migratory potential of rat quiescent hepatic stellate cells and its augmentation by cell activation Hepatology 29 1999 1760 1767
31. J.P. Iredale R.C. Benyon J. Pickering Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors J Clin Invest 102 1998 538 549
32. W.R. Jarnagin D.C. Rockey V.E. Koteliansky Expression of variant fibronectins in wound healing: Cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis J Cell Biol 127 1994 2037 2048
33. A.M. Jezequel G. Novelli C. Venturini Quantitative analysis of the perisinusoidal cells in human liver; the lipocytes Frontiers in Gastrointestinal Research 8 1984 85 90
34. M.M. Kaplan D.W. Alling H.J. Zimmerman A prospective trial of colchicine for primary biliary cirrhosis N Engl J Med 315 1986 1448 1454
35. N. Kawada S. Seki M. Inoue Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells Hepatology 27 1998 1265 1274
36. S. Keiding J.H. Badsberg V. Becker The prognosis of patients with alcoholic liver disease. An international randomized, placebo-controlled trial on the effect of malotilate on survival J Hepatol 20 1994 454 460
37. A.P. Kirk S. Jain S. Pocock Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis Gut 21 1980 78 83
38. I. Kovalszky P. Nagy B. Szende Experimental and human liver fibrogenesis Scand J Gastroenterol Suppl 228 1998 51 55
39. C.L. Lai R.N. Chien N.W. Leung A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group [see comments] N Engl J Med 339 1998 61 68
40. D. Li S.L. Friedman Liver fibrogenesis and the role of hepatic stellate cells: New insights and prospects for therapy J Gastroenterol Hepatol 14 1999 618 633
41. H. Louis J.L. Van Laethem W. Wu Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice [in process citation] Hepatology 28 1998 1607 1615
42. T.F. Luscher R.R. Wenzel Endothelin and endothelin antagonists: Pharmacology and clinical implications Agents Actions Suppl 45 1995 237 253
43. J.J. Maher J.S. Lozier M.K. Scott Rat hepatic stellate cells produce cytokine-induced neutrophil chemoattractant in culture and in vivo Am J Physiol 275 1998 G847 G853
44. N. Manabe M. Chevallier P. Chossegros Interferon-alpha 2b therapy reduces liver fibrosis in chronic non-A, non-B hepatitis: A quantitative histological evaluation Hepatology 18 1993 1344 1349
45. F. Marra R. DeFranco C. Grappone Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: Correlation with monocyte infiltration Am J Pathol 152 1998 423 430
46. F. Marra A. Gentilini M. Pinzani Phosphatidylinositol 3-kinase is required for platelet-derived growth factor's actions on hepatic stellate cells [see comments] Gastroenterology 112 1997 1297 1306
47. F. Marra R.G. Romanelli S. Pastacaldi Monocyte chemotactic protein-1 stimulates hepatic stellate cell migration J Hepatol 28 1998 57
48. F. Marra A.J. Valente M. Pinzani Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines J Clin Invest 92 1993 1674 1680
49. J. McHutchison S. Gordon E. Schiff Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. International Hepatitis Interventional Therapy Group N Engl J Med 339 1998 1485 1492
50. M. Miyamura M. Ono S. Kyotani Effects of sho-saiko-to extract on fibrosis and regeneration of the liver in rats J Pharm Pharmacol 50 1998 97 105
51. P. Muriel Alpha-interferon prevents liver collagen deposition and damage induced by prolonged bile duct obstruction in the rat J Hepatol 24 1996 614 621
52. K. Nakamura M. Yoneda S. Yokohama Efficacy of ursodeoxycholic acid in Japanese patients with type 1 autoimmune hepatitis [see comments] J Gastroenterol Hepatol 13 1998 490 495
53. D. Nelson G. Lauwers J. Lau Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: A pilot trial of interferon nonresponders Gastroenterology 118 2000 655 660
54. N. Nieto S.L. Friedman P. Greenwel CYP2E1-mediated oxidative stress induces collagen type I expression in rat hepatic stellate cells Hepatology 30 1999 987 996
55. T. Niki M. Pekny K. Hellemans Class VI intermediate filament protein nestin is induced during activation of rat hepatic stellate cells [see comments] Hepatology 29 1999 520 527
56. A. Pietrangelo Metals, oxidative stress, and hepatic fibrogenesis Semin Liver Dis 16 1996 13 30
57. A. Pietrangelo F. Borella G. Casalgrandi Antioxidant activity of silybin in vivo during long-term iron overload in rats Gastroenterology 109 1995 1941 1949
58. A. Pietrangelo R. Gualdi G. Casalgrandi Molecular and cellular aspects of iron-induced hepatic cirrhosis in rodents J Clin Invest 95 1995 1824 1831
59. M. Pinzani F. Marra V. Carloni Signal transduction in hepatic stellate cells Liver 18 1998 2 13
60. M. Pinzani S. Milani C. Grappone Expression of platelet-derived growth factor in a model of acute liver injury Hepatology 19 1994 701 707
61. J.L. Poo G. Feldmann S. Erlinger Ursodeoxycholic acid limits liver histologic alterations and portal hypertension induced by bile duct ligation in the rat Gastroenterology 102 1992 1752 1759
62. R.E. Poupon K.D. Lindor K. Cauch-Dudek Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis Gastroenterology 113 1997 884 890
63. T. Poynard P. Bedossa P. Opolon Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups Lancet 349 1997 825 832
64. T. Poynard J. McHutchinson G. Davis Impact of interferon alfa-2b therapy reduces liver fibrosis in chronic non-A, non-B hepatitis: A quantitative histological evaluation Hepatology 28 1998 497A
65. Z. Qi N. Atsuchi A. Ooshima Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat [in process citation] Proc Natl Acad Sci U S A 96 1999 2345 2349
66. P.Y. Rescan O. Loreal J.R. Hassell Distribution and origin of the basement membrane component perlecan in rat liver and primary hepatocyte culture Am J Pathol 142 1993 199 208
67. D.C. Rockey The cellular pathogenesis of portal hypertension: Stellate cell contractility, endothelin, and nitric oxide Hepatology 25 1997 2 5
68. D.C. Rockey J.J. Chung Endothelin antagonism in experimental hepatic fibrosis. Implications for endothelin in the pathogenesis of wound healing J Clin Invest 98 1996 1381 1388
69. D.C. Rockey J.J. Chung Inducible nitric oxide synthase in rat hepatic lipocytes and the effect of nitric oxide on lipocyte contractility J Clin Invest 95 1995 1199 1206
70. D.C. Rockey J.J. Chung Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: Implications for treatment of hepatic fibrosis J Invest Med 42 1994 660 670
71. D.C. Rockey C.N. Housset S.L. Friedman Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo J Clin Invest 92 1993 1795 1804
72. D.C. Rockey J.J. Maher W.R. Jarnagin Inhibition of rat hepatic lipocyte activation in culture by interferon-gamma Hepatology 16 1992 776 784
73. M. Rojkind M.A. Giambrone L. Biempica Collagen types in normal and cirrhotic liver Gastroenterology 76 1979 710 719
74. T. Roskams J. Rosenbaum R. De Vos Heparan sulfate proteoglycan expression in chronic cholestatic human liver diseases Hepatology 24 1996 524 532
75. I. Sakaida Y. Matsumura S. Akiyama Herbal medicine Sho-saiko-to (TJ-9) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet J Hepatol 28 1998 298 306
76. I. Sakaida Y. Matsumura M. Kubota The prolyl 4-hydroxylase inhibitor HOE 077 prevents activation of Ito cells, reducing procollagen gene expression in rat liver fibrosis induced by choline-deficient l -amino acid-defined diet Hepatology 23 1996 755 763
77. I. Shimizu Y.R. Ma Y. Mizobuchi Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats [see comments] Hepatology 29 1999 149 160
78. Y. Shiratori F. Imazeki M. Moriyama Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy Ann Intern Med 132 2000 517 524
79. R. Sobesky P. Mathurin F. Charlotte Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: A dynamic view. The Multivirc Group Gastroenterology 116 1999 378 386
80. M. Spearman W.R. Taylor A.H. Greenberg Antisense oligodeoxyribonucleotide inhibition of TGF-beta 1 gene expression and alterations in the growth and malignant properties of mouse fibrosarcoma cells Gene 149 1994 25 29
81. K. Thompson J. Maltby J. Fallowfield Interleukin-10 expression and function in experimental murine liver inflammation and fibrosis [in process citation] Hepatology 28 1998 1597 1606
82. K.C. Thompson A. Trowern A. Fowell Primary rat and mouse hepatic stellate cells express the macrophage inhibitor cytokine interleukin-10 during the course of activation in vitro [in process citation] Hepatology 28 1998 1518 1524
83. R. Timpl Macromolecular organization of basement membranes Curr Opin Cell Biol 8 1996 618 624
84. T. Toyonaga O. Hino S. Sugai Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver Proc Natl Acad Sci U S A 91 1994 614 618
85. M.L. Tsang L. Zhou B.L. Zheng Characterization of recombinant soluble human transforming growth factor-beta receptor type II (rhTGF-beta sRII) Cytokine 7 1995 389 397
86. T. Ueno M. Sata R. Sakata Hepatic stellate cells and intralobular innervation in human liver cirrhosis Hum Pathol 28 1997 953 959
87. H.R. van Buuren The results of a randomized double blind controlled trial evaluating malotilate in primary biliary cirrhosis. A European multicentre study group J Hepatol 17 1993 227 235
88. S.C. Wang H. Tsukamoto R.A. Rippe Expression of interleukin-10 by in vitro and in vivo activated hepatic stellate cells J Biol Chem 273 1998 302 308
89. X.D. Wang Chronic alcohol intake interferes with retinoid metabolism and signaling Nutr Rev 57 1999 51 59
90. Y.J. Wang S.S. Wang M. Bickel Two novel antifibrotics, HOE 077 and Safironil, modulate stellate cell activation in rat liver injury: Differential effects in males and females Am J Pathol 152 1998 279 287
91. S. Wasser J.M. Ho H.K. Ang Salvia miltiorrhiza reduces experimentally-induced hepatic fibrosis in rats J Hepatol 29 1998 760 771
92. L. Wong G. Yamasaki R.J. Johnson Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture J Clin Invest 94 1994 1563 1569
93. J. Wu A. Danielsson Detection of hepatic fibrogenesis: A review of available techniques Scand J Gastroenterol 30 1995 817 825